LAS INFECCIONES DE TRANSMISIÓN SEXUAL. - Euskadi.net

111. Hooper RR, Reynolds GH, Jones OG, Zaidi
A, Wiesner PJ, Latimer KP, Lester A,
Campbell AF, Harrison WO, Karney WW,
Holmes KK. Cohort study of venereal disease.
I: the risk of gonorrhea transmission
from infected women to men. Am J
Epidemiol 1978 Aug; 108(2):136-44.
112. Hopkins S, Lyons F, Coleman C, Courtney
G, Bergin C, Mulcahy F. Resurgence in infectious
syphilis in Ireland: an epidemiological
study. Sex Transm Dis 2004 May;
31(5):317-21.
113. Hornbrook MC, Hurtado AV, Johnson RE
Health care episodes: definition, measurement
and use. Med Care Rev 1985; 42:
163-218.
114. Horowitz S M. Applying the transtheoretical
model to pregnancy and STD prevention:
a review of the literature. Am J
Health Promot 2003; 7(5): 304-328.
115. Hoyer H, Scheungraber C, Kuehne-Heid
R, Teller K, Greinke C, Leistritz S, Ludwig
B, Durst M, Schneider A. Cumulative 5-
year diagnoses of CIN2, CIN3 or cervical
cancer after concurrent high-risk HPV
and cytology testing in a primary screening
setting. Int J Cancer 2005 Aug 10;
116(1):136-43.
116. INE. Encuesta de salud y hábitos sexuales
2003. Acceso el 13 de septiembre de
2005 en: http://www.ine.es/inebase/
cgi/umM=%2Ft15%2Fp455&O=inebase&N=&L=O.
117. Instituto de la Mujer. Ministerio deTrabajo
y Asuntos Sociales. Protocolo de Prevención
de la Transmisión Heterosexual
del VIH con enfoque de género en Atención
Primaria. Madrid 2004.
118. Jacobs R J, Meyerhoff A S. Cost-effectiveness
of hepatitis A/B vaccine versus hepatitis
B vaccine in public sexually transmitted
disease clinics. Sexually Transmitted
Diseases 2003; 30(11):859-865.
119. Johnson AM, Mercer KH, Cassell JA. Social
determinants, sexual behaviour, and
sexual health. En: Marmot M, Wilkinson
RG. Social determinants of health. Oxford
University Press. 2006.
120. Johnson J.K. Screening for human papillomavirus
infection. In: Canadian Task
Force on the Periodic Health Examination.
Canadian Guide to Clinical Preventive
Health Care. Ottawa: Health Canada,
1994; 768-76. Acceso el 8/8/2005 en:
http://www.ctfphc.org/Full_Text/Ch63f
ull.htm.
121. Johnson K. Periodic health examination,
1995 update: 1. Screening for human papillomavirus
infection in asymptomatic
women. Canadian Task Force on the Periodic
Health Examination. CMAJ 1995
Feb 15; 152(4):483-93.
122. Jones CA, Cunningham AL. Vaccination
strategies to prevent genital herpes and
neonatal herpes simplex virus (HSV) disease.
Herpes 2004 Apr; 11(1):12-7.
123. Jonna S, Collins M, Abedin M, Young M,
Milteer R, Beeram M. Postneonatal screening
for congenital syphilis. Fam Pract
1995 Sep; 41(3):286-8.
124. Kalichman S C, Carey M P, Johnson B T.
Prevention of sexually transmitted HIV
infection: a meta-analytic review of the
behavioral outcome literature. An Behav
Med 1996; 18(1): 6-15.
125. Kalichman SC, Rompa D, Coley B. Experimental
component analysis of a behavioral
HIV-AIDS prevention intervention
for inner-city women. Journal of consulting
and clinical psychology 1996; 64(4):
687-93.
126. Kamenga M, Ryder RW, Jingu M, Mbuyi
N, Mbu L, Behets F, Brown C, Heyward
WL. Evidence of marked sexual behavior
change associated with low HIV-1 seroconversion
in 149 married couples with
discordant HIV-1 serostatus: experience
at an HIV counselling center in Zaire.
AIDS 1991 Jan; 5(1):61-7.
127. Kamwendo F, Forslin L, Bodin L, Danielsson
D. Decreasing incidences of gonorr-
164